| Pharmaceutical active ingredients: |
| GramicidinNeomycin Sulfate |
| Available forms, composition and doses of Graneodin: |
| Ointment; Topical; Neomycin Sulphate 1625 units; Gramicidin 0.025% |
| Graneodin medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R02AB01 - NeomycinR02AB30 - Gramicidin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Bristol-Myers Squibb |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Tivitis | Gramicidin; Methylene Blue; Neomycin Sulfate; Polymyxin B Sulfate; Tetrahydrozoline Hydrochloride | Llorens |
| Biotarson O | Gramicidin; Naphazoline; Neomycin | Ifusa Laboratorios |
| Nasomicina | Gramicidin; Naphazoline; Neomycin | Northia Medicinales |
| Neo-Priphen | Gramicidin; Naphazoline; Neomycin; Phenylephrine | Minerva Pharmaceutical |
| Gramibiotic | Gramicidin; Neomycin | Cordoba Laboratorios |
| Graneodine | Gramicidin; Neomycin Sulfate | Bristol-Myers Squibb |
| Neogram | Gramicidin; Neomycin Sulfate | Societa Industria Farmaceutica Italiana |
| Spectrocin | Gramicidin; Neomycin Sulfate | Bristol-Myers Squibb |
| Spectrocin Ointment | Gramicidin; Neomycin Sulfate | Faes Farma |
| Tri-Adcortyl | Gramicidin; Neomycin Sulfate; Nystatin | Bristol-Myers Squibb |